Literature DB >> 15254683

Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias.

Gennaro Chiappetta1, Francesca Pentimalli, Mario Monaco, Monica Fedele, Rosa Pasquinelli, Giovanna Maria Pierantoni, Maria Teresa Ribecco, Giovanni Santelli, Daniela Califano, Luciano Pezzullo, Alfredo Fusco.   

Abstract

Overexpression of thymosin beta-10 (TB10) has been shown in rat thyroid transformed cell lines, and in human thyroid carcinoma tissues and cell lines. To investigate whether TB10 detection could be a valid tool in the diagnosis of human thyroid neoplasias, we extended the analysis of TB10 expression to a large number of thyroid hyperproliferative and neoplastic tissues using an immunohistochemical assay. Our analyses showed a TB10 positive staining in all human thyroid carcinomas particularly in the anaplastic histotypes, whereas no TB10 immunostaining was observed in normal thyroid, in adenomas and the majority of the goiters. These results suggest that the evaluation of TB10 gene expression may be considered a promising means of diagnosis of human thyroid hyperproliferative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254683

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.

Authors:  Liliána Z Fehér; Gábor Pocsay; László Krenács; Agnes Zvara; Enikő Bagdi; Réka Pocsay; Géza Lukács; Ferenc Győry; Andrea Gazdag; Erzsébet Tarkó; László G Puskás
Journal:  Pathol Oncol Res       Date:  2011-12-11       Impact factor: 3.201

2.  AcSDKP: a new potential marker of malignancy of the thyroid gland.

Authors:  Michal Kusinski; Joanna Wdzieczak-Bakala; Jian-Miao Liu; Jerome Bignon; Krzysztof Kuzdak
Journal:  Langenbecks Arch Surg       Date:  2006-01-18       Impact factor: 3.445

3.  Follicular adenoma and carcinoma of the thyroid gland.

Authors:  Christopher R McHenry; Roy Phitayakorn
Journal:  Oncologist       Date:  2011-04-11

4.  MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer.

Authors:  Baogang J Xu; Adriana L Gonzalez; Takefumi Kikuchi; Kiyoshi Yanagisawa; Pierre P Massion; Huiyun Wu; Stephen E Mason; Sandy J Olson; Yu Shyr; David P Carbone; Richard M Caprioli
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

5.  Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.

Authors:  Sirinapa Sribenja; Kanlayanee Sawanyawisuth; Ratthaphol Kraiklang; Chaisiri Wongkham; Kulthida Vaeteewoottacharn; Sumalee Obchoei; Qizhi Yao; Sopit Wongkham; Changyi Chen
Journal:  BMC Cancer       Date:  2013-09-23       Impact factor: 4.430

6.  Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma.

Authors:  W Theunissen; D Fanni; S Nemolato; E Di Felice; T Cabras; C Gerosa; P Van Eyken; I Messana; M Castagnola; G Faa
Journal:  Eur J Histochem       Date:  2014-03-11       Impact factor: 3.188

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.